MYC and high grade B-cell lymphoma: Fourteen patients were revised to a diagnosis of DLBCL or HGBL, due to disagreement between central and local pathology review (n = 9; 23.7%), administrative errors (n = 2) or absence of fluorescence in situ hybridisation to confirm MYC‐R (n = 3).